Workflow
健康元跌2.05%,成交额2.40亿元,主力资金净流出1563.79万元

Core Viewpoint - Health元's stock price has experienced fluctuations, with a year-to-date increase of 16.71% but a recent decline of 5.07% over the past five trading days [1] Company Overview - Health元 Pharmaceutical Group Co., Ltd. is located in Nanshan District, Shenzhen, Guangdong Province, and was established on December 18, 1992, with its listing date on June 8, 2001 [1] - The company operates as a comprehensive pharmaceutical enterprise, primarily engaged in the research, development, and production of traditional Chinese medicine, health products, and Western medicine [1] - The revenue composition includes: chemical preparations 47.71%, chemical raw materials and intermediates 31.97%, traditional Chinese medicine preparations 10.28%, diagnostic reagents and equipment 4.74%, health food 3.08%, biological products 1.20%, and others 0.86% [1] Financial Performance - For the first half of 2025, Health元 reported operating revenue of 7.898 billion yuan, a year-on-year decrease of 4.08%, while net profit attributable to shareholders increased by 1.10% to 785 million yuan [2] - Since its A-share listing, Health元 has distributed a total of 3.979 billion yuan in dividends, with 1.04 billion yuan distributed in the last three years [3] Shareholder Information - As of June 30, 2025, Health元 had 76,300 shareholders, a decrease of 4.32% from the previous period, with an average of 23,991 circulating shares per person, an increase of 4.52% [2] - The top ten circulating shareholders include Hong Kong Central Clearing Limited as the second-largest shareholder with 68.3785 million shares, an increase of 14.9969 million shares from the previous period [3]